Weight loss shot tested as new weapon against breast cancer recurrence

NCT ID NCT06518837

Recruiting now Disease control Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

Summary

This study is testing if a weight loss medication called tirzepatide can help prevent breast cancer from coming back. It will involve 40 people who have completed treatment for early-stage, hormone-positive breast cancer and are overweight. Researchers want to see if losing weight with this drug improves long-term health and reduces the risk of the cancer returning.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HORMONE-RECEPTOR-POSITIVE BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

RWJ Barnabas Health - Robert Wood Johnson University Hospital, Hamilton
NOT_YET_RECRUITING

Hamilton, New Jersey, 08690, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
RWJ Barnabas Health - Robert Wood Johnson University Hospital, Somerset
RECRUITING

Somerville, New Jersey, 08876, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
RWJBarnabas Health - Cooperman Barnabas, Livingston
RECRUITING

Livingston, New Jersey, 07039, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
RWJBarnabas Health - Monmouth Medical Center
RECRUITING

Long Branch, New Jersey, 07740, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
RWJBarnabas Health - Newark Beth Israel Medical Center
RECRUITING

Newark, New Jersey, 07112, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Rutgers Cancer Institute
RECRUITING

New Brunswick, New Jersey, 08901, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Trinitas Comprehensive Cancer Center
RECRUITING

Elizabeth, New Jersey, 07202, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HER2-NEGATIVE BREAST CANCER HORMONE-RECEPTOR-POSITIVE BREAST CANCER